Nitroglycerin (medication)
(Redirected from Trinipatch)
Nitroglycerin, also known as glyceryl trinitrate, is a medication used for the treatment of angina pectoris, heart failure, and high blood pressure. It is also used in the management of myocardial infarction and Raynaud's phenomenon. Nitroglycerin is available in various forms, including sublingual, oral, transdermal, and intravenous formulations.
Medical Uses[edit | edit source]
Nitroglycerin is primarily used to relieve chest pain associated with angina pectoris. It works by dilating the blood vessels, which reduces the workload on the heart and improves blood flow to the myocardium. This medication is also used in the treatment of heart failure and hypertension.
Angina Pectoris[edit | edit source]
For angina pectoris, nitroglycerin is often administered sublingually for rapid relief of chest pain. It can also be used prophylactically before activities that may provoke angina.
Heart Failure[edit | edit source]
In cases of heart failure, nitroglycerin helps to reduce the symptoms by decreasing the preload and afterload on the heart, thus improving cardiac output.
Hypertension[edit | edit source]
Nitroglycerin is used in the management of hypertensive emergencies due to its potent vasodilatory effects.
Mechanism of Action[edit | edit source]
Nitroglycerin is a nitrovasodilator that releases nitric oxide (NO) in the body. NO activates the enzyme guanylate cyclase, which increases the levels of cyclic guanosine monophosphate (cGMP). Elevated cGMP levels lead to the relaxation of smooth muscle cells in the vascular system, resulting in vasodilation.
Side Effects[edit | edit source]
Common side effects of nitroglycerin include headache, dizziness, and hypotension. Severe side effects may include syncope, tachycardia, and methemoglobinemia.
Contraindications[edit | edit source]
Nitroglycerin should not be used in individuals with severe anemia, closed-angle glaucoma, or hypotension. It is also contraindicated in patients who are taking phosphodiesterase inhibitors such as sildenafil due to the risk of severe hypotension.
History[edit | edit source]
Nitroglycerin was first synthesized by Ascanio Sobrero in 1847. Its medical use was discovered by William Murrell in 1879, who found it effective in treating angina pectoris.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD